- Zacks•10 hours ago
We expect pharma company AbbVie Inc. (ABBV) to beat expectations when it reports third-quarter earnings results on Oct 28 before market open.
- Barrons.com•13 hours ago
Now, Kostin and his team have a new note looking at what S&P 500 companies will do with the cash they bring home. The increase in buyback executions was also accompanied by growth in buyback announcements.
- Zacks•16 hours ago
Given that some companies have an unfavorable Zacks Rank and a lower probability of beating this quarter, healthcare ETFs might struggle to hold onto gains in the coming days.
AbbVie Inc. (ABBV)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||61.08 x 200|
|Ask||61.25 x 200|
|Day's Range||61.02 - 61.68|
|52wk Range||50.71 - 68.12|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||17.63|
|Avg Vol (3m)||6,164,209|
|Dividend & Yield||2.28 (3.74%)|